Precision System Science
Innovative solutions for gene and protein analysis with fully automated real-time molecular testing systems.
| JPY | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | - | 84 % | (20 %) | (29 %) | (25 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | - | 1 % | 12 % | 10 % | (10 %) | (14 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | - | (2 %) | 9 % | 1 % | (25 %) | (28 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Precision System Science Co., Ltd. (PSS) specializes in providing comprehensive solutions for gene and protein analysis, catering to the life sciences and healthcare sectors. The company offers a range of instruments, including DNA and RNA extractors and protein purification systems, designed to streamline and automate the entire process from sample extraction to result analysis. PSS's flagship product line, the geneLEAD series, exemplifies this by automating nucleic acid extraction, amplification, and detection, thus ensuring high accuracy and efficiency in molecular testing.
PSS serves a diverse clientele, including research institutions, clinical laboratories, and biotechnology companies, operating primarily in the analytical and diagnostic markets. The company's business model revolves around the sale of its advanced instruments and related consumables, as well as offering OEM system customization services. Revenue is generated through direct sales, long-term contracts, and collaborative research projects.
PSS leverages its expertise in automation technology and its collaborative network to drive innovation in genetics, proteomics, immunology, and biochemistry. The company is also involved in government projects and presents its advancements at various conferences and exhibitions, further solidifying its position as a leader in the field.
Keywords: gene analysis, protein analysis, molecular testing, automation, geneLEAD series, DNA extraction, RNA extraction, protein purification, life sciences, healthcare.
